National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 413 cases where Vaccine is HPV or HPV2 or HPV4 and Patient Died

Case Details

This is page 25 out of 42

Result pages: prev   16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34   next


VAERS ID: 489011 (history)  
Form: Version 1.0  
Age: 18.0  
Sex: Female  
Location: Foreign  
Vaccinated:2013-04-06
Onset:2013-04-06
   Days after vaccination:0
Submitted: 2013-04-11
   Days after onset:5
Entered: 2013-04-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA173AE / 2 LA / IM

Administered by: Other       Purchased by: Other
Symptoms: Acute pulmonary oedema, Blood pressure abnormal, Cardiac arrest, Cyanosis, Death, Electrocardiogram abnormal, Mechanical ventilation, Mydriasis, Peripheral coldness, Respiratory arrest, Resuscitation
SMQs:, Torsade de pointes/QT prolongation (broad), Cardiac failure (narrow), Anaphylactic reaction (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypertension (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Hypersensitivity (broad), Respiratory failure (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2013-04-06
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Blood pressure, 06Apr2013, 100/60; Blood pressure, 06Apr2013, 0; Body temperature, 06Apr2013, 36.5deg.C; Electrocardiogram, 06Apr2013, Flatten; Heart rate, 06Apr2013, 0
CDC Split Type: B0882178A

Write-up: This case was reported by a physician via a sales representative and described the occurrence of death due to acute pulmonary edema in a 18-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). Concurrent vaccination included 1st dose of CERVARIX (GlaxoSmithKline) given in 6 March 2013 and which was uneventfully. The subject had no concurrent illness, allergies or relevant medical history. On 6 April 2013, at 9 - 10:00AM, the subject received 2nd dose of CERVARIX (.5 ml, intramuscular, left arm). She stayed in the medical center for 30 minutes before making her way home. No reaction was observed during this period. On 6 April 2013, in the afternoon, less than one day after vaccination with CERVARIX, the subject was found as breathless. On the same day, at 17:20, the subject was brought to a 1st hospital for emergency and was hospitalised with cardiac arrest and breathless. The subject had cardiopulmonary resuscitation and face mask ventilation. The subject did not recover and was transferred to a 2nd hospital with cyanosis, cold hands and legs, nul blood pressure and heard beep, mydriasis, body temperature of 36.5 deg.C and flatten ECG. The subject was treated with NaCl and adrenaline. The emergency cares were stopped after 45 minutes by lack of any signal of recovery. The subject finally died due to acute pulmonary edema.


VAERS ID: 495540 (history)  
Form: Version 1.0  
Age: 31.0  
Sex: Female  
Location: Foreign  
Vaccinated:2006-05-02
Onset:2012-09-25
   Days after vaccination:2338
Submitted: 2013-06-28
   Days after onset:276
Entered: 2013-06-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS VX17027 / 1 LA / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2012-09-25
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Subject was enrolled in Vaccine Trial and received 3 doses of CERVARIX. Following closeout from CVT in 12/17/2010, patient continued in Extended Follow-up Study (since 8/1/2011). At study visit on 6/21/2013, parents-in-law of patient reported she passed away at home on 9/25/2012. Patient has hx of severe dilated cardiomyopathy starting in 2008, and suffered severe respiratory illnesses and a stroke in 2010 and 2011, respectively. Cause of death was believed to be related to her underlying heart condition and not related to vaccination.


VAERS ID: 497193 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2013-01-03
Onset:0000-00-00
Submitted: 2013-07-18
Entered: 2013-07-19
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 2 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Congenital absence of cranial vault, Congenital adrenal gland hypoplasia, Congenital diaphragmatic hernia, Death, Foetal exposure during pregnancy, Pulmonary hypoplasia
SMQs:, Congenital, familial and genetic disorders (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2013-03-11
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Maternal exposure timing unspecified
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1307DNK009995

Write-up: Case was received by a physician via the Health Authorities on 08-Jul-2013 under the reference DK-DKMA-ADR 22166169. Case medically confirmed. This case is linked to case E2013-05277 (patient''s mother, same vaccine). A foetus had received the second dose of GARDASIL (batch number not reported) via transplacental route on 03-Jan-2013 as the mother of the patient had been vaccinated with GARDASIL. On an unspecified date the patient developed absence of cranial vault, congenital diaphragmatic hernia, congenital adrenal gland hypoplasia and pulmonary hypoplasia. Abortion was induced. The patient died on 11-Mar-2013. Autopsy was determined. It was reported that the mother was 19 gestation week at the time of the events but it was not specified whether it was at the time of vaccination, at the time of induced abortion or at the time of congenital anomalies diagnosis. The mother received D1 of GARDASIL on 06-Nov-2012, toleration not reported.


VAERS ID: 500640 (history)  
Form: Version 1.0  
Age: 22.0  
Sex: Female  
Location: Foreign  
Vaccinated:2010-03-01
Onset:2010-04-01
   Days after vaccination:31
Submitted: 2013-08-27
   Days after onset:1244
Entered: 2013-08-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death, Encephalitis autoimmune, General physical health deterioration, Headache, Immunoglobulin therapy, Intensive care, Loss of consciousness
SMQs:, Torsade de pointes/QT prolongation (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Noninfectious encephalitis (narrow), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1308ISR009992

Write-up: This spontaneous report as received from a gynecologist refers to a 22 year old female patient with no history of sexual activity who was married with a young male with no history of sexual activity, both were not at risk group for HPV. In March 2010, the patient was possibly vaccinated with the first dose of GARDASIL (Lot # not reported, expiration date and route not specified). The physician reported that in April 2010, after one month of vaccination, following a day of hiking the patient complained to her husband at the evening about a headache and within a short time the patient lost consciousness. The patient was hospitalized at the intensive care unit under the diagnosis of autoimmune inflammation of the brain. Despite intensive treatments that included immunoglobulin therapy and wide and global consultations the patient''s condition deteriorated and the patient passed away after several days in April 2010. No post-mortem autopsy was performed. The physician felt that severe autoimmune inflammation of the brain was not related to vaccination with GARDASIL. The physician stated that hospital''s physicians did not relate the event to vaccination with GARDASIL and it was never raised as a cause. The reporter stated that the patient''s sister mentioned at one point that might be the patient was not vaccinated with GARDASIL after all and only had a prescription at that time. Additional information has been requested.


VAERS ID: 502329 (history)  
Form: Version 1.0  
Age: 11.0  
Sex: Female  
Location: Foreign  
Vaccinated:2013-05-05
Onset:2013-05-08
   Days after vaccination:3
Submitted: 2013-09-12
   Days after onset:127
Entered: 2013-09-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Convulsion, Death, Neurological decompensation, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Convulsions (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Generalised convulsive seizures following immunisation (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2013-05-08
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1309COL004119

Write-up: This spontaneous report as received from a regulatory authority (AE13CO0200) refers to an 11 year old female patient. On 05-MAY-2013 the patient was vaccinated with her first and only dose of GARDASIL, 0.5 ml, intramuscular (site and lot number not provided). Three days after, on 08-MAY-2013, the patient experienced fever, seizures, neurological deterioration and death. The outcome of seizures, fever and neurological deterioration was reported as fatal. The cause of death was not reported. According to the investigation performed by the regulatory authority, the patient was healthy previous to the vaccination; the events were experienced only after the vaccination. No evidences of external issues as the cause of the events were found. As additional information, no samples of cerebrospinal fluid were taken (in order to discard meningitis). The causal relationship was not reported. Upon internal review, seizures was medically significant. Additional information has been requested.


VAERS ID: 506585 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Female  
Location: Foreign  
Vaccinated:2011-08-30
Onset:0000-00-00
Submitted: 2013-10-07
Entered: 2013-10-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA143CA / 2 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Biopsy bone abnormal, Death, Imaging procedure, Osteosarcoma, Pain, Surgery, Swelling
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Osteonecrosis (broad), Non-haematological malignant tumours (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Biopsy, 22Nov2011, osteosarcoma; Imaging procedure, 21Nov2011, osteosarcoma
CDC Split Type: B0927643A

Write-up: This case was reported by a physician via regulatory authority and described the occurrence of osteosarcoma in a 14-year-old female patient subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject was previously healthy. Concurrent vaccination included 1st dose of CERVARIX (GlaxoSmithKline, intramuscular) given on 29 July 2011. On 30 August 2011, the subject received 2nd dose of CERVARIX (intramuscular, unknown injection site). In 2011, less than one year after vaccination with CERVARIX, the subject presented with marked swelling and pain. The following evening the pain subsided and the subject did not visit the hospital. In early October 2011, the subject was aware of the pain at the tumor site. On 21 November 2011, diagnostic imaging revealed osteosarcoma, which had developed within the past several months. On 22 November 2011, biopsy was performed. On 29 November 2011, diagnosis was confirmed. On 5 December 2011, the subject was admitted to hospital and was treated with cytotoxic agent (Unknown cancer therapy drug) and underwent a surgery. The physician considered the event was unrelated to vaccination with CERVARIX. It was considered that the causal relationship between the vaccine and the onset of osteosarcoma had not been medically confirmed. The subject died from osteosarcoma. It was unknown whether an autopsy was performed.


VAERS ID: 509519 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2013-10-25
Entered: 2013-10-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Cervix carcinoma
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1310RUS011669

Write-up: This spontaneous report as received from a social media website refers to a 14 year old female patient. On an unknown date the patient was vaccinated with GARDASIL (dose, strength, route and site of administration not reported) for cervical cancer. On an unknown date the patient died. The reason of death was not reported. Additional information is not expected.


VAERS ID: 513145 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2013-11-14
Entered: 2013-11-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1311ISR005786

Write-up: Information was received from a lawyer who reported that since 2006, approximately 21,000 people reported side effects due to the Quadrivalent GARDASIL including 73 fatalities. Additional information is not expected.


VAERS ID: 515823 (history)  
Form: Version 1.0  
Age: 10.0  
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2013-12-06
Entered: 2013-12-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Epilepsy
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1312CAN001830

Write-up: This spontaneous report as received from a physician refers to a 9-10 year old female patient with epileptic seizures. On an unknown date the patient was vaccinated with GARDASIL. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient passed away three weeks after receiving her vaccine. The relatedness of the death is unknown for with GARDASIL. Additional information has been requested.


VAERS ID: 516461 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Female  
Location: Foreign  
Vaccinated:2013-12-09
Onset:2013-12-10
   Days after vaccination:1
Submitted: 2013-12-12
   Days after onset:2
Entered: 2013-12-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0542AE / 2 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2013-12-10
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1312NZL004481

Write-up: This spontaneous report as received from a agency through a phone call refers to a 16 year old female patient. On 09-DEC-2013, the patient was vaccinated with the second dose of GARDASIL (Lot# 0542AE; exp. date: 21-MAR-2015) (dose and route not provided). She also received the script for oral contraceptives (no other details provided). On 10-DEC-2013, in the morning, the girl was found death in her bed. No other details were available. It was noted that a post mortem will be conducted but no date had been set. The cause of death was reported as unknown. It was noted that the country immunization network contacted the Ministry of Health who contacted personnel in another agency. Agency were not planning any media release at this stage, as very few details were available. Additional information is not expected.


Result pages: prev   16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=25&VAX[]=HPV&VAX[]=HPV2&VAX[]=HPV4&DIED=Yes


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166